New York Life Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
New York Life Investment Management's MDT Position: Q4 2025 in Review
New York Life Investment Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 174,127 shares — an estimated $16.6M sold.
New York Life Investment Management first reported a position in MDT in Q2 2022 and held it in 14 quarters. The position peaked at $17.1M in Q2 2022. 2,308 funds tracked by Wall St. Rank hold MDT as of Q4 2025.
- New York Life Investment Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
- New York Life Investment Management sold 174,127 Medtronic shares in Q4 2025, an estimated $16.6M.
- New York Life Investment Management first reported a position in Medtronic in Q2 2022 and held it in 14 quarters.
- New York Life Investment Management's Medtronic position peaked at $17.1M in Q2 2022.
- 2,308 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.
Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.